Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

Iris A.S. Stroot*, Joost Bart, Harry Hollema, Mathilde Jalving, Marise M. Wagner, Refika Yigit, Helena C. van Doorn, Joanne A. de Hullu, Katja N. Gaarenstroom, Marc van Beurden, Luc R.C.W. van Lonkhuijzen, Brigitte F.M. Slangen, Ronald P. Zweemer, Encarna B. Gómez García, Margreet G.E.M. Ausems, Ingrid A. Boere, Liselotte P. van Hest, Floor A.M. Duijkers, Christi J. van Asperen, Marjanka K. SchmidtMarijke R. Wevers, Marielle W.G. Ruijs, Peter Devilee, J. Margriet Collée, investigators HEBON investigators, Geertruida H. de Bock, Marian J.E. Mourits

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Agricultural and Biological Sciences